From: Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?
Ref | Jadad score | Disorder | Meds | Age | Gen | Omega-3 fatty acid | Prep type | Duration | N | Outcome measure | Average baseline score | Δ | Statistical significance vs. placebo |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
37 | 4 | OCD | 100% | 34 | 73% | 2 g/day EPA | Ethyl EPA | 6 weeks | 11 | YBOCS | 26 | -0.9 | No |
 |  |  |  |  |  |  |  |  |  | HDRS | 11 | NS | No |
 |  |  |  |  |  |  |  |  |  | HARS | 14 | NS | No |
41 | 4 | SUA | 42% | 51 | 0% | 450 mg/day EPA 100 mg/day DHA | Crude mixture | 3 months | 24 | POMS-T | 4.3 | -2.9 | Yes |